Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

RE: A reappraisal of sex-specific cancer survival trends among adolescents and young adults in the United States.

Siegel SE, Coccia PF, Barr R, Hayes-Lattin B, Bleyer A.

J Natl Cancer Inst. 2019 Feb 21. pii: djz019. doi: 10.1093/jnci/djz019. [Epub ahead of print] No abstract available.

PMID:
30793191
2.

Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens.

Siegel SE, Advani A, Seibel N, Muffly L, Stock W, Luger S, Shah B, DeAngelo DJ, Freyer DR, Douer D, Johnson RH, Hayes-Lattin B, Lewis M, Jaboin JJ, Coccia PF, Bleyer A.

Am J Hematol. 2018 Oct;93(10):1254-1266. doi: 10.1002/ajh.25229. Epub 2018 Sep 3. Review.

3.

Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.

Siegel SE, Stock W, Johnson RH, Advani A, Muffly L, Douer D, Reed D, Lewis M, Freyer DR, Shah B, Luger S, Hayes-Lattin B, Jaboin JJ, Coccia PF, DeAngelo DJ, Seibel N, Bleyer A.

JAMA Oncol. 2018 May 1;4(5):725-734. doi: 10.1001/jamaoncol.2017.5305. Review.

PMID:
29450465
4.

Children, adolescents, and young adults with leukemia: the empty half of the glass is growing.

Bleyer A, Siegel SE, Coccia PF, Stock W, Seibel NL.

J Clin Oncol. 2012 Nov 10;30(32):4037-8; author reply 4038-9. doi: 10.1200/JCO.2012.44.7466. Epub 2012 Oct 1. No abstract available.

PMID:
23032621
5.

Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.

Horton TM, Sposto R, Brown P, Reynolds CP, Hunger SP, Winick NJ, Raetz EA, Carroll WL, Arceci RJ, Borowitz MJ, Gaynon PS, Gore L, Jeha S, Maurer BJ, Siegel SE, Biondi A, Kearns PR, Narendran A, Silverman LB, Smith MA, Zwaan CM, Whitlock JA; ALLNA 2008 Conference.

Pediatr Blood Cancer. 2010 Jul 1;54(7):872-8. doi: 10.1002/pbc.22414.

6.

Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation.

Meeske KA, Siegel SE, Gilsanz V, Bernstein L, Nelson MB, Sposto R, Weaver FA, Lavey RS, Mack MP, Nelson MD Jr.

Pediatr Blood Cancer. 2009 Oct;53(4):615-21. doi: 10.1002/pbc.22111.

7.

Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.

Schulman EA, Lake AE 3rd, Goadsby PJ, Peterlin BL, Siegel SE, Markley HG, Lipton RB.

Headache. 2008 Jun;48(6):778-82. doi: 10.1111/j.1526-4610.2008.01132.x. Epub 2008 May 14.

8.
9.

Obesity and outcome in pediatric acute lymphoblastic leukemia.

Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu C, Franklin J, Siegel SE, Seibel NL, Rogers PC, Sather H, Trigg M, Bleyer WA, Carroll WL.

J Clin Oncol. 2007 May 20;25(15):2063-9.

PMID:
17513811
10.

Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy.

Nasir A, Boulware D, Kaiser HE, Lancaster JM, Coppola D, Smith PV, Hakam A, Siegel SE, Bodey B.

In Vivo. 2007 Jan-Feb;21(1):35-43.

11.

Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors.

Bodey B, Siegel SE, Kaiser HE.

In Vivo. 2006 Jul-Aug;20(4):519-25.

13.

Evaluation of persistent pulmonary infiltrates in pediatric oncology patients.

Armenian SH, La Via WV, Siegel SE, Mascarenhas L.

Pediatr Blood Cancer. 2007 Feb;48(2):165-72.

PMID:
16411212
14.

Mechanisms and markers of carcinogenesis and neoplastic progression.

Bodey B, Bodey B Jr, Siegel SE.

Expert Opin Biol Ther. 2005 Oct;5(10):1317-32. Review.

PMID:
16197337
15.

Prevalence and correlates of fatigue in long-term survivors of childhood leukemia.

Meeske KA, Siegel SE, Globe DR, Mack WJ, Bernstein L.

J Clin Oncol. 2005 Aug 20;23(24):5501-10.

PMID:
16110010
16.

Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.

Bodey B, Kaiser HE, Siegel SE.

In Vivo. 2005 Sep-Oct;19(5):931-41.

17.
18.

Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.

Bodey B, Bodey V, Siegel SE, Kaiser HE.

In Vivo. 2004 Nov-Dec;18(6):713-8.

19.

Immunocytochemical detection of members of the caspase cascade of apoptosis in high-grade astrocytomas.

Bodey B, Bodey V, Siegel SE, Nasir A, Coppola D, Hakam A, Kaiser HE.

In Vivo. 2004 Sep-Oct;18(5):593-602.

20.

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.

Cancer. 2004 Oct 15;101(8):1873-81.

21.

Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).

Panosyan EH, Grigoryan RS, Avramis IA, Seibel NL, Gaynon PS, Siegel SE, Fingert HJ, Avramis VI.

Anticancer Res. 2004 Mar-Apr;24(2C):1121-5.

22.

Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.

Panosyan EH, Seibel NL, Martin-Aragon S, Gaynon PS, Avramis IA, Sather H, Franklin J, Nachman J, Ettinger LJ, La M, Steinherz P, Cohen LJ, Siegel SE, Avramis VI; Children's Cancer Group Study CCG-1961.

J Pediatr Hematol Oncol. 2004 Apr;26(4):217-26.

PMID:
15087948
23.
24.

Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia.

Wu SQ, Weinberg KI, Joo WJ, Quinn JJ, Franklin J, Siegel SE, Gaynon PS.

J Pediatr Hematol Oncol. 2003 Jul;25(7):520-5.

PMID:
12847317
25.

Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.

Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL.

Br J Haematol. 2003 Feb;120(4):660-70.

PMID:
12588354
26.

Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience.

Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL.

Am J Hematol. 2003 Jan;72(1):53-63. Review.

27.
28.
29.

Racial differences in childhood tumors.

Kaiser HE, Bodey V, Siegel SE, Bodey B.

In Vivo. 2002 Nov-Dec;16(6):417-22. Review.

PMID:
12494884
30.

Restoration of the thymic cellular microenvironment following autologous bone marrow transplantation.

Bodey B, Siegel SE, Kaiser HE.

In Vivo. 2002 Mar-Apr;16(2):127-40.

PMID:
12073772
31.

Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.

Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE.

Med Pediatr Oncol. 2001 Nov;37(5):432-41.

PMID:
11745871
32.

Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2001 May-Jun;21(3B):2021-8.

PMID:
11497292
33.

Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):3-16. Review.

PMID:
11418297
34.

Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.

Bodey B, Bodey B Jr, Gröger AM, Siegel SE, Kaiser HE.

In Vivo. 2001 Mar-Apr;15(2):175-80.

PMID:
11317524
35.
36.

Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

In Vivo. 2001 Jan-Feb;15(1):65-70.

PMID:
11286132
37.
38.

Spontaneous neoplastic regression: the significance of apoptosis.

Kaiser HE, Bodey B Jr, Siegel SE, Gröger AM, Bodey B.

In Vivo. 2000 Nov-Dec;14(6):773-88.

PMID:
11212857
40.

Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

In Vivo. 2000 Sep-Oct;14(5):667-73.

PMID:
11212844
41.

Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

In Vivo. 2000 Sep-Oct;14(5):659-66.

PMID:
11212843
42.

Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2000 Nov-Dec;20(6B):4585-90.

PMID:
11210857
43.

Matrix metalloproteinase expression in childhood astrocytomas.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2000 Sep-Oct;20(5A):3287-92.

PMID:
11062755
44.

Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in breast carcinomas.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2000 Sep-Oct;20(5A):3281-6.

PMID:
11062754
45.

Homeobox B3, B4, and C6 gene product expression in osteosarcomas as detected by immunocytochemistry.

Bodey B, Bodey B Jr, Siegel SE, Luck JV, Kaiser HE.

Anticancer Res. 2000 Jul-Aug;20(4):2717-21.

PMID:
10953349
46.

Immunocytochemical detection of homeobox B3, B4, and C6 gene product expression in lung carcinomas.

Bodey B, Bodey B Jr, Gröger AM, Siegel SE, Kaiser HE.

Anticancer Res. 2000 Jul-Aug;20(4):2711-6.

PMID:
10953348
47.

Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2000 Jul-Aug;20(4):2665-76. Review.

PMID:
10953341
48.

The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2000 May-Jun;20(3A):1871-88.

PMID:
10928121
49.

Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2000 May-Jun;20(3A):1769-80.

PMID:
10928106
50.

Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.

Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.

Anticancer Res. 2000 May-Jun;20(3A):1759-68.

PMID:
10928105

Supplemental Content

Loading ...
Support Center